Latest period
$40.69M
YoY change
+7.3%
5Y CAGR
+4.8%
Peak year (2021)
$48.98M
Latest annual
$40.83M
Stock-Based Compensation history chart for Bio-Techne (TECH) from 1990 to 2025
Latest: $40.83M
Stock-Based Compensation growth chart for Bio-Techne (TECH) from 1990 to 2025
Latest: +7.3%
Stock-Based Compensation history table for Bio-Techne (TECH) from 1990 to 2025
| 2025 | $40.83M | +7.3% | +$2.79M | ||
| 2024 | $38.04M | -3.0% | −$1.19M | ||
| 2023 | $39.23M | -7.0% | −$2.95M | ||
| 2022 | $42.18M | -13.9% | −$6.80M | ||
| 2021 | $48.98M | +51.3% | +$16.61M | ||
| 2020 | $32.37M | +0.3% | +$87.00K | ||
| 2019 | $32.28M | +14.3% | +$4.04M | ||
| 2018 | $28.24M | +93.0% | +$13.61M | ||
| 2017 | $14.63M | +55.2% | +$5.20M | ||
| 2016 | $9.43M | +58.3% | +$3.47M | ||
| 2015 | $5.96M | +69.1% | +$2.43M | ||
| 2014 | $3.52M | +89.0% | +$1.66M | ||
| 2013 | $1.86M | +13.6% | +$223.00K | ||
| 2012 | $1.64M | +44.2% | +$503.00K | ||
| 2011 | $1.14M | +0.3% | +$3.00K | ||
| 2010 | $1.14M | -23.2% | −$343.00K | ||
| 2009 | $1.48M | — | +$1.48M | ||
| 2008 | $0.00 | — | $0.00 | ||
| 2007 | $0.00 | — | $0.00 | ||
| 2006 | $0.00 | — | $0.00 | ||
| 2005 | $0.00 | — | $0.00 | ||
| 2004 | $0.00 | — | $0.00 | ||
| 2003 | $0.00 | — | $0.00 | ||
| 2002 | $0.00 | — | $0.00 | ||
| 2001 | $0.00 | — | $0.00 | ||
| 2000 | $0.00 | — | $0.00 | ||
| 1999 | $0.00 | — | $0.00 | ||
| 1998 | $0.00 | — | $0.00 | ||
| 1997 | $0.00 | — | $0.00 | ||
| 1996 | $0.00 | — | $0.00 | ||
| 1995 | $0.00 | — | $0.00 | ||
| 1994 | $0.00 | — | $0.00 | ||
| 1993 | $0.00 | — | $0.00 | ||
| 1992 | $0.00 | — | $0.00 | ||
| 1991 | $0.00 | — | $0.00 | ||
| 1990 | $0.00 | — | — |
- 2025$40.83M+7.3%
- 2024$38.04M-3.0%
- 2023$39.23M-7.0%
- 2022$42.18M-13.9%
- 2021$48.98M+51.3%
- 2020$32.37M+0.3%
- 2019$32.28M+14.3%
- 2018$28.24M+93.0%
- 2017$14.63M+55.2%
- 2016$9.43M+58.3%
- 2015$5.96M+69.1%
- 2014$3.52M+89.0%
- 2013$1.86M+13.6%
- 2012$1.64M+44.2%
- 2011$1.14M+0.3%
- 2010$1.14M-23.2%
- 2009$1.48M—
- 2008$0.00—
- 2007$0.00—
- 2006$0.00—
- 2005$0.00—
- 2004$0.00—
- 2003$0.00—
- 2002$0.00—
- 2001$0.00—
- 2000$0.00—
- 1999$0.00—
- 1998$0.00—
- 1997$0.00—
- 1996$0.00—
- 1995$0.00—
- 1994$0.00—
- 1993$0.00—
- 1992$0.00—
- 1991$0.00—
- 1990$0.00—
Stock-Based Compensation values are taken from Bio-Techne's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Stock-Based Compensation at Bio-Techne (TECH)
Stock-Based Compensation for Bio-Techne (TECH): headline value $40.69M · YoY +7.3%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2025's annual stock-based compensation for Bio-Techne (TECH) came in at $40.83M – grew 7.3% year-over-year.
Across 2020–2025 (5 years), Bio-Techne stock-based compensation produced a CAGR of +4.8% – with mixed annual results across the window.
2021 marks the peak stock-based compensation at $48.98M, with the historical low of $0.00 recorded in 1990.
Bio-Techne Stock-Based Compensation by Year
Bio-Techne Stock-Based Compensation 2025: $40.83M
Bio-Techne posted stock-based compensation of $40.83M in 2025, grew 7.3% from 2024.
Bio-Techne Stock-Based Compensation 2024: $38.04M
In 2024, Bio-Techne reported stock-based compensation of $38.04M, edged down 3.0% below 2023.
Bio-Techne Stock-Based Compensation 2023: $39.23M
Bio-Techne stock-based compensation in 2023 was $39.23M, declined 7.0% below 2022.
Bio-Techne Stock-Based Compensation 2022: $42.18M
2022's stock-based compensation for Bio-Techne came in at $42.18M, declined 13.9% below 2021.
Bio-Techne Stock-Based Compensation 2021: $48.98M
Bio-Techne stock-based compensation in 2021 was $48.98M.
See more financial history for Bio-Techne (TECH).
Sector peers by Stock-Based Compensation
Healthcare peers of Bio-Techne (TECH), ranked by their latest stock-based compensation
| $1.35B | |
| $971.00M | |
| $955.00M | |
| $626.00M | |
| $0.00 | |
| $0.00 | |
| $0.00 | |
| $0.00 |
- $1.35B
- $971.00M
- $955.00M
- $626.00M
- $0.00
- $0.00
- $0.00
- $0.00
Frequently asked questions
Bio-Techne (TECH) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation